ScaleReady’s Post

The April Sector Snapshot from Alliance for Regenerative Medicine highlights important trends driving #celltherapy development. ARM is dedicated to bringing this valuable data forward to help gain clearer insights into the current state of the advanced therapy industry. Learn about recent approvals for #geneediting therapies like Casgevy and Libmeldy, as well as breakthroughs in cell therapy such as Lifileucel and Fidanacogene Elaparvovec. The report underscores a promising year ahead for cell therapy, with a focus on treating #solidtumors and #autoimmunediseases. Download the full PDF report now to see the outlook of the 2024 regulatory pipeline and trends driving cell therapy development. 

If you're an early cell therapy developer, this webinar on Thursday will be time well spent. Learn from our experts about the journey to first-in-human studies. #celltherapy #drugdevelopment

Check out how we utilize the modularity of the Pin-point™ platform, the aptamer-recruited base editing system, to introduce multiple discrete modifications simultaneously, including targeted integration, and to create complex edited cell therapies in one-step process. Our paper is now published in #MolecularTherapy https://lnkd.in/dEh3g92r

Interested in learning about select scalable GMP ancillary materials to enhance your control over quality and safety standards? Fill out this form to watch our webinar about regulatory requirements for GMP ancillary materials and the importance of regulatory documentation and support to enable successful clinical translation of cell and gene therapies.

Interested in learning about select scalable GMP ancillary materials to enhance your control over quality and safety standards? Fill out this form to watch our webinar about regulatory requirements for GMP ancillary materials and the importance of regulatory documentation and support to enable successful clinical translation of cell and gene therapies.

Interested in learning about select scalable GMP ancillary materials to enhance your control over quality and safety standards? Fill out this form to watch our webinar about regulatory requirements for GMP ancillary materials and the importance of regulatory documentation and support to enable successful clinical translation of cell and gene therapies.

If you need to optimise your cell therapy workflow in this webinar, Dr. Dominika Nackiewicz will discuss some techniques that might solve some of your difficulties. https://lnkd.in/dYkpygXU

🚨 🚨 WEBINAR!🚨 🚨 Unlike the latest dance craze or cat video, there are advantages to going non-viral. Exploring ways to move away from vector-mediated gene delivery in your cell therapy programs? Take this opportunity to hear from industry peers on approaches to non-viral editing.

Gene editing, bioprinting, and stem cell therapy are redefining the biopharma market. These technologies are impacting everything from R&D investments to regulatory landscapes. 👉 Swipe through our carousel to learn how these advancements are creating new market opportunities, shifting competitive dynamics, and presenting unique challenges that every life sciences professional should know about. Want the full picture? Read the article for more insights on navigating this evolving market: https://lnkd.in/evRVUB7h #Biopharma #MarketTrends #GeneEditing #StemCellTherapy #Bioprinting

Discover the importance of effective manufacturing and quality control in cell therapy production from @Matthew Hewitt in this Genetic Engineering & Biotechnology News article. Find out more at: https://bit.ly/4djgaym